English
简体中文
Total: £ 56.28
Published Date: 2026-02-03 | Pages: 108 | Tables: 104 | New Technology
The global Chip-based Oligonucleotide Synthesis market was valued at US$ 49.71 million in 2025 and is anticipated to reach US$ 215 million by 2032, at a CAGR of 23.6% from 2026 to 2032.
Chip-based oligonucleotide synthesis is a high-throughput, cost-effective method utilizing microarray chips to mass-produce short DNA or RNA fragments. Compared to traditional synthesis methods, this technology offers faster speed, higher precision, and greater flexibility, making it especially suitable for fields like gene editing, synthetic biology, and genome sequencing. By enabling parallel synthesis, researchers can simultaneously produce thousands to millions of different oligonucleotide sequences on a single chip, significantly improving experimental efficiency and data output, thereby accelerating research and applications in the life sciences.
The North American market for Chip-based Oligonucleotide Synthesis is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Chip-based Oligonucleotide Synthesis is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Chip-based Oligonucleotide Synthesis in Scientific Research is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Chip-based Oligonucleotide Synthesis include Thermo Fisher, GenScript, LC Sciences, Twist Bioscience, Agilent Technologies, Evonetix, Dynegene Technologies, LC-Bio Technologies, Atantares, BGI Genomics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report focuses on the global Chip-based Oligonucleotide Synthesis status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Chip-based Oligonucleotide Synthesis development in different regions.
It segments the global Chip-based Oligonucleotide Synthesis market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Chip-based Oligonucleotide Synthesis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Thermo Fisher
GenScript
LC Sciences
Twist Bioscience
Agilent Technologies
Evonetix
Dynegene Technologies
LC-Bio Technologies
Atantares
BGI Genomics
Segment by Type
Photochemical Method
Electrochemical Method
Inkjet Printing Method
Segment by Application
Scientific Research
Others
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chip-based Oligonucleotide Synthesis Market Size Growth Rate by Type (2026-2032)
1.2.2 Photochemical Method
1.2.3 Electrochemical Method
1.2.4 Inkjet Printing Method
1.3 Market by Application
1.3.1 Global Chip-based Oligonucleotide Synthesis Market Share by Application (2026-2032)
1.3.2 Scientific Research
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Chip-based Oligonucleotide Synthesis Market Size
2.2 Chip-based Oligonucleotide Synthesis Market Size by Region
2.2.1 Chip-based Oligonucleotide Synthesis Growth Rate by Region (2026-2032)
2.2.2 Chip-based Oligonucleotide Synthesis Market Share by Region (2026-2032)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Chip-based Oligonucleotide Synthesis Revenue by Players (2026 & 2032)
3.2 Chip-based Oligonucleotide Synthesis Key Players Headquarters and Area Served
3.3 Key Players Chip-based Oligonucleotide Synthesis Product/Solution/Service
3.4 Date of Enter into Chip-based Oligonucleotide Synthesis Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and Application
4.1 Global Chip-based Oligonucleotide Synthesis Market Size by Type (2026-2032)
4.2 Global Chip-based Oligonucleotide Synthesis Market Size by Application (2026-2032)
5 North America
5.1 North America Chip-based Oligonucleotide Synthesis Market Forecast (2026-2032)
5.2 Chip-based Oligonucleotide Synthesis Key Players in North America
5.3 North America Chip-based Oligonucleotide Synthesis Market Size by Type
5.4 North America Chip-based Oligonucleotide Synthesis Market Size by Application
6 Europe
6.1 Europe Chip-based Oligonucleotide Synthesis Market Forecast (2026-2032)
6.2 Chip-based Oligonucleotide Synthesis Key Players in Europe
6.3 Europe Chip-based Oligonucleotide Synthesis Market Size by Type
6.4 Europe Chip-based Oligonucleotide Synthesis Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Chip-based Oligonucleotide Synthesis Market Forecast (2026-2032)
7.2 Chip-based Oligonucleotide Synthesis Key Players in Asia-Pacific
7.3 Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size by Type
7.4 Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America Chip-based Oligonucleotide Synthesis Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa Chip-based Oligonucleotide Synthesis Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Players Profiles
9.1 Thermo Fisher
9.1.1 Thermo Fisher Company Details
9.1.2 Thermo Fisher Description and Business Overview
9.1.3 Thermo Fisher Chip-based Oligonucleotide Synthesis Introduction
9.1.4 Thermo Fisher Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.1.5 Thermo Fisher Recent Development
9.2 GenScript
9.2.1 GenScript Company Details
9.2.2 GenScript Description and Business Overview
9.2.3 GenScript Chip-based Oligonucleotide Synthesis Introduction
9.2.4 GenScript Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.2.5 GenScript Recent Development
9.3 LC Sciences
9.3.1 LC Sciences Company Details
9.3.2 LC Sciences Description and Business Overview
9.3.3 LC Sciences Chip-based Oligonucleotide Synthesis Introduction
9.3.4 LC Sciences Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.3.5 LC Sciences Recent Development
9.4 Twist Bioscience
9.4.1 Twist Bioscience Company Details
9.4.2 Twist Bioscience Description and Business Overview
9.4.3 Twist Bioscience Chip-based Oligonucleotide Synthesis Introduction
9.4.4 Twist Bioscience Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.4.5 Twist Bioscience Recent Development
9.5 Agilent Technologies
9.5.1 Agilent Technologies Company Details
9.5.2 Agilent Technologies Description and Business Overview
9.5.3 Agilent Technologies Chip-based Oligonucleotide Synthesis Introduction
9.5.4 Agilent Technologies Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.5.5 Agilent Technologies Recent Development
9.6 Evonetix
9.6.1 Evonetix Company Details
9.6.2 Evonetix Description and Business Overview
9.6.3 Evonetix Chip-based Oligonucleotide Synthesis Introduction
9.6.4 Evonetix Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.6.5 Evonetix Recent Development
9.7 Dynegene Technologies
9.7.1 Dynegene Technologies Company Details
9.7.2 Dynegene Technologies Description and Business Overview
9.7.3 Dynegene Technologies Chip-based Oligonucleotide Synthesis Introduction
9.7.4 Dynegene Technologies Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.7.5 Dynegene Technologies Recent Development
9.8 LC-Bio Technologies
9.8.1 LC-Bio Technologies Company Details
9.8.2 LC-Bio Technologies Description and Business Overview
9.8.3 LC-Bio Technologies Chip-based Oligonucleotide Synthesis Introduction
9.8.4 LC-Bio Technologies Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.8.5 LC-Bio Technologies Recent Development
9.9 Atantares
9.9.1 Atantares Company Details
9.9.2 Atantares Description and Business Overview
9.9.3 Atantares Chip-based Oligonucleotide Synthesis Introduction
9.9.4 Atantares Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.9.5 Atantares Recent Development
9.10 BGI Genomics
9.10.1 BGI Genomics Company Details
9.10.2 BGI Genomics Description and Business Overview
9.10.3 BGI Genomics Chip-based Oligonucleotide Synthesis Introduction
9.10.4 BGI Genomics Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.10.5 BGI Genomics Recent Development
10 Chip-based Oligonucleotide Synthesis Market Dynamics
10.1 Chip-based Oligonucleotide Synthesis Industry Trends
10.2 Chip-based Oligonucleotide Synthesis Market Drivers
10.3 Chip-based Oligonucleotide Synthesis Market Challenges
10.4 Chip-based Oligonucleotide Synthesis Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details
List of Tables
Table 1. Global Chip-based Oligonucleotide Synthesis Market Size Growth Rate by Type (2026-2032) & (US$ Million)
Table 2. Key Players of Photochemical Method
Table 3. Key Players of Electrochemical Method
Table 4. Key Players of Inkjet Printing Method
Table 5. Global Chip-based Oligonucleotide Synthesis Market Size Growth by Application (2026-2032) & (US$ Million)
Table 6. Global Chip-based Oligonucleotide Synthesis Market Size by Region (2026-2032) & (US$ Million)
Table 7. Global Chip-based Oligonucleotide Synthesis Market Size by Region (2026-2032) & (US$ Million)
Table 8. Global Chip-based Oligonucleotide Synthesis Market Share by Region (2026-2032)
Table 9. Market Top Trends
Table 10. Market Use Cases
Table 11. Global Chip-based Oligonucleotide Synthesis Revenue by Players (2026 & 2032) & (US$ Million)
Table 12. Global Chip-based Oligonucleotide Synthesis Market Share by Players (2026 & 2032)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Chip-based Oligonucleotide Synthesis Product/Solution/Service
Table 15. Date of Enter into Chip-based Oligonucleotide Synthesis Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Chip-based Oligonucleotide Synthesis Market Size by Type (2026-2032) & (US$ Million)
Table 18. Global Chip-based Oligonucleotide Synthesis Market Size Share by Type (2026-2032)
Table 19. Global Chip-based Oligonucleotide Synthesis Market Size by Application (2026-2032) & (US$ Million)
Table 20. Global Chip-based Oligonucleotide Synthesis Market Size Share by Application (2026-2032)
Table 21. North America Key Players Chip-based Oligonucleotide Synthesis Revenue (2026 & 2032) & (US$ Million)
Table 22. North America Key Players Chip-based Oligonucleotide Synthesis Market Share (2026 & 2032)
Table 23. North America Chip-based Oligonucleotide Synthesis Market Size by Type (2026-2032) & (US$ Million)
Table 24. North America Chip-based Oligonucleotide Synthesis Market Share by Type (2026-2032)
Table 25. North America Chip-based Oligonucleotide Synthesis Market Size by Application (2026-2032) & (US$ Million)
Table 26. North America Chip-based Oligonucleotide Synthesis Market Share by Application (2026-2032)
Table 27. Europe Key Players Chip-based Oligonucleotide Synthesis Revenue (2026 & 2032) & (US$ Million)
Table 28. Europe Key Players Chip-based Oligonucleotide Synthesis Market Share (2026 & 2032)
Table 29. Europe Chip-based Oligonucleotide Synthesis Market Size by Type (2026-2032) & (US$ Million)
Table 30. Europe Chip-based Oligonucleotide Synthesis Market Share by Type (2026-2032)
Table 31. Europe Chip-based Oligonucleotide Synthesis Market Size by Application (2026-2032) & (US$ Million)
Table 32. Europe Chip-based Oligonucleotide Synthesis Market Share by Application (2026-2032)
Table 33. Asia-Pacific Key Players Chip-based Oligonucleotide Synthesis Revenue (2026 & 2032) & (US$ Million)
Table 34. Asia-Pacific Key Players Chip-based Oligonucleotide Synthesis Market Share (2026 & 2032)
Table 35. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size by Type (2026-2032) & (US$ Million)
Table 36. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Share by Type (2026-2032)
Table 37. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size by Application (2026-2032) & (US$ Million)
Table 38. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Share by Application (2026-2032)
Table 39. Key Players in Latin America
Table 40. Key Players in Middle East & Africa
Table 41. Thermo Fisher Company Details
Table 42. Thermo Fisher Description and Business Overview
Table 43. Thermo Fisher Chip-based Oligonucleotide Synthesis Product
Table 44. Thermo Fisher Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
Table 45. Thermo Fisher Recent Development
Table 46. GenScript Company Details
Table 47. GenScript Description and Business Overview
Table 48. GenScript Chip-based Oligonucleotide Synthesis Product
Table 49. GenScript Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
Table 50. GenScript Recent Development
Table 51. LC Sciences Company Details
Table 52. LC Sciences Description and Business Overview
Table 53. LC Sciences Chip-based Oligonucleotide Synthesis Product
Table 54. LC Sciences Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
Table 55. LC Sciences Recent Development
Table 56. Twist Bioscience Company Details
Table 57. Twist Bioscience Description and Business Overview
Table 58. Twist Bioscience Chip-based Oligonucleotide Synthesis Product
Table 59. Twist Bioscience Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
Table 60. Twist Bioscience Recent Development
Table 61. Agilent Technologies Company Details
Table 62. Agilent Technologies Description and Business Overview
Table 63. Agilent Technologies Chip-based Oligonucleotide Synthesis Product
Table 64. Agilent Technologies Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
Table 65. Agilent Technologies Recent Development
Table 66. Evonetix Company Details
Table 67. Evonetix Description and Business Overview
Table 68. Evonetix Chip-based Oligonucleotide Synthesis Product
Table 69. Evonetix Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
Table 70. Evonetix Recent Development
Table 71. Dynegene Technologies Company Details
Table 72. Dynegene Technologies Description and Business Overview
Table 73. Dynegene Technologies Chip-based Oligonucleotide Synthesis Product
Table 74. Dynegene Technologies Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
Table 75. Dynegene Technologies Recent Development
Table 76. LC-Bio Technologies Company Details
Table 77. LC-Bio Technologies Description and Business Overview
Table 78. LC-Bio Technologies Chip-based Oligonucleotide Synthesis Product
Table 79. LC-Bio Technologies Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
Table 80. LC-Bio Technologies Recent Development
Table 81. Atantares Company Details
Table 82. Atantares Description and Business Overview
Table 83. Atantares Chip-based Oligonucleotide Synthesis Product
Table 84. Atantares Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
Table 85. Atantares Recent Development
Table 86. BGI Genomics Company Details
Table 87. BGI Genomics Description and Business Overview
Table 88. BGI Genomics Chip-based Oligonucleotide Synthesis Product
Table 89. BGI Genomics Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
Table 90. BGI Genomics Recent Development
Table 91. Chip-based Oligonucleotide Synthesis Market Trends
Table 92. Chip-based Oligonucleotide Synthesis Market Drivers
Table 93. Chip-based Oligonucleotide Synthesis Market Challenges
Table 94. Chip-based Oligonucleotide Synthesis Market Restraints
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chip-based Oligonucleotide Synthesis Market Share by Type in 2026 & 2032
Figure 2. Photochemical Method Features
Figure 3. Electrochemical Method Features
Figure 4. Inkjet Printing Method Features
Figure 5. Global Chip-based Oligonucleotide Synthesis Market Share by Application in 2026 & 2032
Figure 6. Scientific Research Case Studies
Figure 7. Others Case Studies
Figure 8. Chip-based Oligonucleotide Synthesis Report Years Considered
Figure 9. Global Chip-based Oligonucleotide Synthesis Market Size and Growth Rate 2026-2032 (US$ Million)
Figure 10. Global Chip-based Oligonucleotide Synthesis Market Share by Region (2026-2032)
Figure 11. Global Chip-based Oligonucleotide Synthesis Market Size Market Share by Type (2026-2032)
Figure 12. North America Chip-based Oligonucleotide Synthesis Market Size 2026-2032 (US$ Million)
Figure 13. Europe Chip-based Oligonucleotide Synthesis Market Size 2026-2032 (US$ Million)
Figure 14. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size 2026-2032 (US$ Million)
Figure 15. Chip-based Oligonucleotide Synthesis Market Size in Latin America (2026-2032) & (US$ Million)
Figure 16. Chip-based Oligonucleotide Synthesis Market Size in Middle East & Africa (2026-2032) & (US$ Million)
Figure 17. Bottom-up and Top-down Approaches for This Report
Figure 18. Data Triangulation
Figure 19. Key Executives Interviewed
